PMID- 23372150
OWN - NLM
STAT- MEDLINE
DCOM- 20130319
LR  - 20210202
IS  - 1528-0020 (Electronic)
IS  - 0006-4971 (Linking)
VI  - 121
IP  - 5
DP  - 2013 Jan 31
TI  - Haplo-BMT: which approach?
PG  - 719-20
LID - 10.1182/blood-2012-12-469981 [doi]
AB  - In patients with hematologic malignancies, Di Bartolomeo et al report encouraging 
      outcomes after transplantation of granulocyte-colony stimulating factor (G-CSF)- 
      primed unmanipulated bone marrow from human leukocyte antigen (HLA)- haplotype 
      mismatched (haploidentical) related donors, suggesting that this procedure makes 
      haploidentical transplantation available in all transplant centers.
FAU - Velardi, Andrea
AU  - Velardi A
AD  - University of Perugia.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Blood
JT  - Blood
JID - 7603509
RN  - 143011-72-7 (Granulocyte Colony-Stimulating Factor)
SB  - IM
CON - Blood. 2013 Jan 31;121(5):849-57. PMID: 23165479
MH  - *Bone Marrow Transplantation
MH  - Female
MH  - Granulocyte Colony-Stimulating Factor/*administration & dosage
MH  - Hematologic Neoplasms/*mortality/*therapy
MH  - Humans
MH  - *Living Donors
MH  - Male
EDAT- 2013/02/02 06:00
MHDA- 2013/03/21 06:00
CRDT- 2013/02/02 06:00
PHST- 2013/02/02 06:00 [entrez]
PHST- 2013/02/02 06:00 [pubmed]
PHST- 2013/03/21 06:00 [medline]
AID - S0006-4971(20)43222-7 [pii]
AID - 10.1182/blood-2012-12-469981 [doi]
PST - ppublish
SO  - Blood. 2013 Jan 31;121(5):719-20. doi: 10.1182/blood-2012-12-469981.